ADIPOQ and atherosclerosis: Hypoadiponectin results in twofold increase in coronary artery diseases in men (Kumada et al., 2003), but development of atherosclerosis was suppressed in mice with increased plasma levels of adiponectin (Okamoto et al., 2002; Trivedi et al., 2012a).